hydroxychloroquine has been researched along with Dysphagia in 3 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hydroxychloroquine is a valuable treatment for morphea because of its high response rate and low rate of adverse effects; however, prospective studies are needed to determine its true efficacy." | 1.51 | Treatment of morphea with hydroxychloroquine: A retrospective review of 84 patients at Mayo Clinic, 1996-2013. ( Blixt, EK; Drage, LA; El-Azhary, RA; Kumar, AB; Wetter, DA, 2019) |
| "Lipodystrophy was seen in 10/33 (30." | 1.33 | Twelve years experience of juvenile dermatomyositis in North India. ( Bansal, A; Singh, S, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, AB | 1 |
| Blixt, EK | 1 |
| Drage, LA | 1 |
| El-Azhary, RA | 1 |
| Wetter, DA | 1 |
| Singh, S | 1 |
| Bansal, A | 1 |
| Mateen, FJ | 1 |
| Keegan, BM | 1 |
3 other studies available for hydroxychloroquine and Dysphagia
| Article | Year |
|---|---|
Treatment of morphea with hydroxychloroquine: A retrospective review of 84 patients at Mayo Clinic, 1996-2013.
Topics: Adolescent; Adult; Aged; Autoantibodies; Autoimmune Diseases; Child; Deglutition Disorders; Drug Eva | 2019 |
Twelve years experience of juvenile dermatomyositis in North India.
Topics: Adolescent; Age of Onset; Azathioprine; Calcinosis; Child; Child, Preschool; Deglutition Disorders; | 2006 |
Severe, reversible dysphagia from chloroquine and hydroxychloroquine myopathy.
Topics: Aged, 80 and over; Antirheumatic Agents; Chloroquine; Deglutition Disorders; Humans; Hydroxychloroqu | 2007 |